Search images on Google Product Monograph
Active Ingredients:
- risankizumab, 360 MG/2.4 ML
DIN: 02532093
Dosage Form(s): SOLUTION
Route(s) of Administration: SUBCUTANEOUS
Description: PRE-FILLED CATRIDGE WITH ON-BODY INJECTOR
Schedule: Prescription
Company: ABBVIE CORPORATION
ATC:
- L04 - IMMUNOSUPPRESSANTS (ATC, WHO, Wiki)
- L04A - IMMUNOSUPPRESSANTS (ATC, WHO)
- L04AC - Interleukin inhibitors (ATC, WHO)
- L04AC18 - RIZANKIZUMAB (WHO)